Hollow crystalline straws of diclofenac for high-dose and carrier-free dry powder inhaler formulations
[Display omitted] To crystallize diclofenac (DF) from diclofenac sodium (DFNa), to micronize DF and DFNa, and to evaluate in vitro aerodynamic performance of the jet-milled formulations From the acidic titration of aqueous DFNa, DF crystals were formed and were identified using thermal analysis, spe...
Saved in:
Published in | International journal of pharmaceutics Vol. 502; no. 1-2; pp. 170 - 180 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
11.04.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | [Display omitted]
To crystallize diclofenac (DF) from diclofenac sodium (DFNa), to micronize DF and DFNa, and to evaluate in vitro aerodynamic performance of the jet-milled formulations
From the acidic titration of aqueous DFNa, DF crystals were formed and were identified using thermal analysis, spectroscopy, and X-ray powder diffraction. Following the micronization of the DF and DFNa powders, the recovered samples were imaged, and their particle size distributions were evaluated. Samples before and after jet millings were characterized, and in vitro aerodynamic performance testing was performed on the DF sample before jet milling and the DF and DFNa samples following jet milling.
Hollow needles of DF were precipitated. With similar particle size distributions, the jet-milled DFNa sample from the collection bag, and the DF sample from the cyclone were used for further characterization. Despite different deposition patterns in the Next Generation Impactor, the DF hollow needles had a comparable respirable fraction percentage to the jet-milled DF and DFNa particles. However, the jet-milled DF formulation had the best in vitro aerodynamic performance.
Hollow, crystalline needles of DF were formed and possessed promising aerosol performance in comparison with the jet-milled powders. |
---|---|
AbstractList | To crystallize diclofenac (DF) from diclofenac sodium (DFNa), to micronize DF and DFNa, and to evaluate in vitro aerodynamic performance of the jet-milled formulations
From the acidic titration of aqueous DFNa, DF crystals were formed and were identified using thermal analysis, spectroscopy, and X-ray powder diffraction. Following the micronization of the DF and DFNa powders, the recovered samples were imaged, and their particle size distributions were evaluated. Samples before and after jet millings were characterized, and in vitro aerodynamic performance testing was performed on the DF sample before jet milling and the DF and DFNa samples following jet milling.
Hollow needles of DF were precipitated. With similar particle size distributions, the jet-milled DFNa sample from the collection bag, and the DF sample from the cyclone were used for further characterization. Despite different deposition patterns in the Next Generation Impactor, the DF hollow needles had a comparable respirable fraction percentage to the jet-milled DF and DFNa particles. However, the jet-milled DF formulation had the best in vitro aerodynamic performance.
Hollow, crystalline needles of DF were formed and possessed promising aerosol performance in comparison with the jet-milled powders. OBJECTIVETo crystallize diclofenac (DF) from diclofenac sodium (DFNa), to micronize DF and DFNa, and to evaluate in vitro aerodynamic performance of the jet-milled formulationsMATERIALS AND METHODSFrom the acidic titration of aqueous DFNa, DF crystals were formed and were identified using thermal analysis, spectroscopy, and X-ray powder diffraction. Following the micronization of the DF and DFNa powders, the recovered samples were imaged, and their particle size distributions were evaluated. Samples before and after jet millings were characterized, and in vitro aerodynamic performance testing was performed on the DF sample before jet milling and the DF and DFNa samples following jet milling.RESULTS AND DISCUSSIONHollow needles of DF were precipitated. With similar particle size distributions, the jet-milled DFNa sample from the collection bag, and the DF sample from the cyclone were used for further characterization. Despite different deposition patterns in the Next Generation Impactor, the DF hollow needles had a comparable respirable fraction percentage to the jet-milled DF and DFNa particles. However, the jet-milled DF formulation had the best in vitro aerodynamic performance.CONCLUSIONSHollow, crystalline needles of DF were formed and possessed promising aerosol performance in comparison with the jet-milled powders. [Display omitted] To crystallize diclofenac (DF) from diclofenac sodium (DFNa), to micronize DF and DFNa, and to evaluate in vitro aerodynamic performance of the jet-milled formulations From the acidic titration of aqueous DFNa, DF crystals were formed and were identified using thermal analysis, spectroscopy, and X-ray powder diffraction. Following the micronization of the DF and DFNa powders, the recovered samples were imaged, and their particle size distributions were evaluated. Samples before and after jet millings were characterized, and in vitro aerodynamic performance testing was performed on the DF sample before jet milling and the DF and DFNa samples following jet milling. Hollow needles of DF were precipitated. With similar particle size distributions, the jet-milled DFNa sample from the collection bag, and the DF sample from the cyclone were used for further characterization. Despite different deposition patterns in the Next Generation Impactor, the DF hollow needles had a comparable respirable fraction percentage to the jet-milled DF and DFNa particles. However, the jet-milled DF formulation had the best in vitro aerodynamic performance. Hollow, crystalline needles of DF were formed and possessed promising aerosol performance in comparison with the jet-milled powders. |
Author | Yazdi, Ashkan K. Smyth, Hugh D.C. |
Author_xml | – sequence: 1 givenname: Ashkan K. surname: Yazdi fullname: Yazdi, Ashkan K. email: ashkan.k.yazdi@utexas.edu, ashkan.k.yazdi@gmail.com – sequence: 2 givenname: Hugh D.C. surname: Smyth fullname: Smyth, Hugh D.C. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26911418$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkEtrWzEQhUVJaBynP6FFy2zujR73uQol5AWBbpq1GEujWkZXcqTrGv_7KNjtNsziMHDOHOa7JGchBiTkO2c1Z7y72dRus11DmmpR1pqJmkn2hSz40MtKNn13RhZM9kPV8l5ekMucN4yxTnD5lVyIbuS84cOC2KfofdxTnQ55Bu9dQJrnBPtMo6XGaR8tBtDUxkTX7s-6MjEjhWCohpQcpsomRGrSgW7j3mCiLqzBFy2JaedhdjHkK3JuwWf8dtIleX24_333VL38eny--_lS6UbyuRJyJbUdesEGzrTBxlomutUIrANhpB05jDCiBY4wDNDYFphFLoVpYeBtL5fk-nh3m-LbDvOsJpc1eg8B4y4r3vdNK2VbZknao1WnmHNCq7bJTZAOijP1gVht1Amx-kCsmFAFccn9OFXsVhOa_6l_TIvh9mjA8ujfQkhl7TBoNC6hnpWJ7pOKd6DKk24 |
CitedBy_id | crossref_primary_10_1021_acsabm_3c00162 crossref_primary_10_1021_acs_molpharmaceut_8b00907 crossref_primary_10_3390_ma11050864 crossref_primary_10_1016_j_ijpharm_2022_121914 crossref_primary_10_1016_j_powtec_2020_08_063 crossref_primary_10_1016_j_apt_2020_03_028 crossref_primary_10_1016_j_ijpharm_2021_121259 crossref_primary_10_1016_j_ijpharm_2017_06_002 crossref_primary_10_1016_j_ijpharm_2021_120568 crossref_primary_10_1007_s40199_024_00520_3 crossref_primary_10_1021_acs_cgd_9b00292 crossref_primary_10_1016_j_molstruc_2020_128066 crossref_primary_10_1016_j_saa_2021_120018 crossref_primary_10_1021_acs_molpharmaceut_7b00690 crossref_primary_10_1021_acs_cgd_7b00099 crossref_primary_10_1208_s12249_022_02480_w crossref_primary_10_1016_j_ijpharm_2018_07_065 crossref_primary_10_1021_acs_molpharmaceut_9b01085 crossref_primary_10_1016_j_ijpharm_2018_05_036 crossref_primary_10_3390_pharmaceutics15020674 crossref_primary_10_3390_pharmaceutics13010031 crossref_primary_10_3390_pharmaceutics15122706 |
Cites_doi | 10.1016/j.ijpharm.2011.05.043 10.1107/S0108270197002126 10.1016/j.ijpharm.2008.04.044 10.1378/chest.124.1.360 10.1021/cg900969n 10.1152/physrev.00004.2008 10.1007/s11095-007-9475-1 10.1046/j.1365-2125.2003.01892.x 10.1016/j.ijpharm.2012.03.020 10.1146/annurev.pa.33.040193.002251 10.1208/s12249-010-9542-5 10.1134/S1990793110070018 10.1177/193229681200600406 10.1016/S0168-3659(02)00460-1 10.1183/09031936.00071312 10.3810/psm.2013.05.2016 10.1016/j.jcrysgro.2011.10.060 10.3164/jcbn.10-79 10.1002/jps.20943 10.1007/s11095-010-0215-6 10.1016/S0140-6736(94)91843-0 10.1016/j.ijpharm.2003.10.039 10.1246/cl.2005.1422 10.1016/0584-8539(95)01479-9 10.1021/la100449z 10.1590/S0104-66322008000200016 10.1021/jm0612970 |
ContentType | Journal Article |
Copyright | 2016 Elsevier B.V. Copyright © 2016 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2016 Elsevier B.V. – notice: Copyright © 2016 Elsevier B.V. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.ijpharm.2016.02.030 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-3476 |
EndPage | 180 |
ExternalDocumentID | 10_1016_j_ijpharm_2016_02_030 26911418 S0378517316301235 |
Genre | Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 4.4 457 4G. 5GY 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AATCM AAXUO ABFNM ABFRF ABJNI ABMAC ABOCM ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W KOM M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SDP SES SPCBC SSP SSZ T5K TEORI ~02 ~G- AAQFI AAXKI AKRWK CGR CUY CVF ECM EIF NPM .GJ 29J 3O- 53G 5VS AAQXK AAYXX ABXDB ADMUD AFJKZ ASPBG AVWKF AZFZN CITATION FEDTE FGOYB G-2 HMT HVGLF HZ~ R2- SEW SPT WUQ ZXP 7X8 |
ID | FETCH-LOGICAL-c431t-23b3cf8720810cde4ff026b9a06a2d3f91a9a9efa1ea88a4f5a0fe132d5a81573 |
IEDL.DBID | .~1 |
ISSN | 0378-5173 |
IngestDate | Sat Oct 26 01:39:00 EDT 2024 Thu Sep 26 16:34:30 EDT 2024 Sat Sep 28 07:57:50 EDT 2024 Fri Feb 23 02:34:25 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1-2 |
Keywords | ρ DF FT-IR DFNa HR Jet milling XRD Diclofenac sodium (PubChem CID: 5018304) Diclofenac HCl FPF5μm Precipitation FPF3μm Sodium dodecyl sulfate (PubChem CID: 3423265 DSC Next generation impactor GSD Tween 20 (PubChem CID: 443314) FPF1μm ED SSA MOC Diclofenac (PubChem CID: 3033) Dry powder inhaler ρB CI MMAD BET NGI USP ρT RF Diclofenac sodium SEM FPF HPMC |
Language | English |
License | Copyright © 2016 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c431t-23b3cf8720810cde4ff026b9a06a2d3f91a9a9efa1ea88a4f5a0fe132d5a81573 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 26911418 |
PQID | 1774533535 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_1774533535 crossref_primary_10_1016_j_ijpharm_2016_02_030 pubmed_primary_26911418 elsevier_sciencedirect_doi_10_1016_j_ijpharm_2016_02_030 |
PublicationCentury | 2000 |
PublicationDate | 2016-04-11 |
PublicationDateYYYYMMDD | 2016-04-11 |
PublicationDate_xml | – month: 04 year: 2016 text: 2016-04-11 day: 11 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | International journal of pharmaceutics |
PublicationTitleAlternate | Int J Pharm |
PublicationYear | 2016 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Boss, Petrucci, Lorber (bib0015) 2012; 6 Llinàs, Burley, Box, Glen, Goodman (bib0095) 2007; 50 Eddleston, Jones (bib0040) 2010; 10 USP General Chapter (bib0145) 2015 USP General Chapter (bib0150) 2015 Zalepugin, Tilkunova, Fronchek, Gallyamov, Chernyshova, Mishin, Yashin, Grigoryev, Gamzazade, Khokhlov (bib0185) 2010; 4 Labiris, Dolovich (bib0085) 2003 Klinge, Sawyer (bib0075) 2013; 41 Yazdi, Smyth (bib0180) 2015 Hira, Okuda, Kito, Ishizeki, Okada, Okamoto (bib0055) 2010; 27 Murray, Brater (bib0105) 1993; 33 Shariare, de Matas, York (bib0130) 2011; 415 Cabaniss, McVey (bib0020) 1995; 51 Xiao, Liu, Mi, Yuan, Zhang, Cheng (bib0175) 2005; 34 Newhouse, Hirst, Duddu, Walter, Tarara, Clark, Weers (bib0110) 2003; 124 Center for Drug Evaluation Research (bib0030) Hinds (bib0050) 2012 Rodriguez, Jick (bib0120) 1994; 343 Telko, Hickey (bib0140) 2005; 50 Hickey, Mansour, Telko, Xu, Smyth, Mulder, McLean, Langridge, Papadopoulos (bib0045) 2007; 96 Lexi-Comp Inc., 2015. Diclofenac [WWW Document] (accessed 08.26.15.). Bae, Yazaydın, Snurr (bib0005) 2010; 26 Kubavat, Shur, Ruecroft, Hipkiss, Price (bib0080) 2012; 430 Dodd, A., Meiser, F., Norret, M., Russell, A., Bosch, H.W., 2014. Formulation of diclofenac. US8679544 B2. Beck, Lionzo, Costa, Benvenutti, Ré, Gallas, Pohlmann, Guterres (bib0010) 2008; 25 Iroko Pharmaceuticals, LLC, 2013. Zorvolex (R) [package insert]. Steckel, Bolzen (bib0135) 2004; 270 Novartis, 2013. Tobi Podhaler (R) [Package insert]. Saleem, Smyth (bib0125) 2010; 11 Vehring (bib0160) 2008; 25 Castellari, Ottani (bib0025) 1997; 53 Ikegami, Kawashima, Takeuchi, Yamamoto, Mimura, Mamose, Ouchi (bib0060) 2003; 88 Wallace (bib0165) 2008; 88 Wilson, Welte, Polverino, Soyza, Greville, ODonnell, Alder, Reimnitz, Hampel (bib0170) 2013; 41 Ulrich, Schuster, Stelzer (bib0155) 2013; 362 Matsui, Shimokawa, Kaneko, Nagano, Rai, Hyodo (bib0100) 2011; 48 Islam, Gladki (bib0070) 2008; 360 Center for Drug Evaluation Research (10.1016/j.ijpharm.2016.02.030_bib0030) Beck (10.1016/j.ijpharm.2016.02.030_bib0010) 2008; 25 Yazdi (10.1016/j.ijpharm.2016.02.030_bib0180) 2015 10.1016/j.ijpharm.2016.02.030_bib0065 Steckel (10.1016/j.ijpharm.2016.02.030_bib0135) 2004; 270 Hinds (10.1016/j.ijpharm.2016.02.030_bib0050) 2012 Kubavat (10.1016/j.ijpharm.2016.02.030_bib0080) 2012; 430 Ulrich (10.1016/j.ijpharm.2016.02.030_bib0155) 2013; 362 10.1016/j.ijpharm.2016.02.030_bib0115 Bae (10.1016/j.ijpharm.2016.02.030_bib0005) 2010; 26 Zalepugin (10.1016/j.ijpharm.2016.02.030_bib0185) 2010; 4 Hira (10.1016/j.ijpharm.2016.02.030_bib0055) 2010; 27 Llinàs (10.1016/j.ijpharm.2016.02.030_bib0095) 2007; 50 Shariare (10.1016/j.ijpharm.2016.02.030_bib0130) 2011; 415 Wallace (10.1016/j.ijpharm.2016.02.030_bib0165) 2008; 88 Ikegami (10.1016/j.ijpharm.2016.02.030_bib0060) 2003; 88 Hickey (10.1016/j.ijpharm.2016.02.030_bib0045) 2007; 96 Telko (10.1016/j.ijpharm.2016.02.030_bib0140) 2005; 50 Klinge (10.1016/j.ijpharm.2016.02.030_bib0075) 2013; 41 USP General Chapter (10.1016/j.ijpharm.2016.02.030_bib0145) 2015 Vehring (10.1016/j.ijpharm.2016.02.030_bib0160) 2008; 25 Wilson (10.1016/j.ijpharm.2016.02.030_bib0170) 2013; 41 10.1016/j.ijpharm.2016.02.030_bib0090 Saleem (10.1016/j.ijpharm.2016.02.030_bib0125) 2010; 11 10.1016/j.ijpharm.2016.02.030_bib0035 USP General Chapter (10.1016/j.ijpharm.2016.02.030_bib0150) 2015 Cabaniss (10.1016/j.ijpharm.2016.02.030_bib0020) 1995; 51 Matsui (10.1016/j.ijpharm.2016.02.030_bib0100) 2011; 48 Newhouse (10.1016/j.ijpharm.2016.02.030_bib0110) 2003; 124 Xiao (10.1016/j.ijpharm.2016.02.030_bib0175) 2005; 34 Castellari (10.1016/j.ijpharm.2016.02.030_bib0025) 1997; 53 Eddleston (10.1016/j.ijpharm.2016.02.030_bib0040) 2010; 10 Labiris (10.1016/j.ijpharm.2016.02.030_bib0085) 2003 Murray (10.1016/j.ijpharm.2016.02.030_bib0105) 1993; 33 Boss (10.1016/j.ijpharm.2016.02.030_bib0015) 2012; 6 Islam (10.1016/j.ijpharm.2016.02.030_bib0070) 2008; 360 Rodriguez (10.1016/j.ijpharm.2016.02.030_bib0120) 1994; 343 |
References_xml | – volume: 10 start-page: 365 year: 2010 end-page: 370 ident: bib0040 article-title: Formation of tubular crystals of pharmaceutical compounds publication-title: Cryst. Growth Des. contributor: fullname: Jones – start-page: 588 year: 2003 end-page: 599 ident: bib0085 article-title: Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications publication-title: Br. J. Clin. Pharmacol. contributor: fullname: Dolovich – year: 2012 ident: bib0050 article-title: Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles contributor: fullname: Hinds – volume: 360 start-page: 1 year: 2008 end-page: 11 ident: bib0070 article-title: Dry powder inhalers (DPIs)—a review of device reliability and innovation publication-title: Int. J. Pharm. contributor: fullname: Gladki – volume: 53 start-page: 794 year: 1997 end-page: 797 ident: bib0025 article-title: Two monoclinic forms of diclofenac acid publication-title: Acta Crystallogr. Sect. C contributor: fullname: Ottani – volume: 33 start-page: 435 year: 1993 end-page: 465 ident: bib0105 article-title: Renal toxicity of the nonsteroidal anti-Inflammatory drugs publication-title: Annu. Rev. Pharmacol. Toxicol. contributor: fullname: Brater – start-page: 523 year: 2015 end-page: 528 ident: bib0180 article-title: Effect of capsule fill weight on device resistance in dry powder inhalers publication-title: Respiratory Drug Delivery contributor: fullname: Smyth – volume: 25 start-page: 389 year: 2008 end-page: 398 ident: bib0010 article-title: Surface morphology of spray-dried nanoparticle-coated microparticles designed as an oral drug delivery system publication-title: Braz. J. Chem. Eng. contributor: fullname: Guterres – volume: 48 start-page: 107 year: 2011 end-page: 111 ident: bib0100 article-title: The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestine publication-title: J. Clin. Biochem. Nutr. contributor: fullname: Hyodo – ident: bib0030 article-title: Drug Safety and Availability-FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes [WWW Document] contributor: fullname: Center for Drug Evaluation Research – volume: 25 start-page: 999 year: 2008 end-page: 1022 ident: bib0160 article-title: Pharmaceutical particle engineering via spray drying publication-title: Pharm. Res. contributor: fullname: Vehring – volume: 88 start-page: 23 year: 2003 end-page: 33 ident: bib0060 article-title: A new agglomerated KSR-592 beta-form crystal system for dry powder inhalation formulation to improve inhalation performance in vitro and in vivo publication-title: J. Controlled Release contributor: fullname: Ouchi – start-page: 1326 year: 2015 end-page: 1330 ident: bib0145 article-title: Powder flow publication-title: US Pharmacopeial Convention contributor: fullname: USP General Chapter <1174> – volume: 11 start-page: 1642 year: 2010 end-page: 1649 ident: bib0125 article-title: Micronization of a soft material: air-Jet and micro-Ball milling publication-title: AAPS PharmSciTech contributor: fullname: Smyth – volume: 270 start-page: 297 year: 2004 end-page: 306 ident: bib0135 article-title: Alternative sugars as potential carriers for dry powder inhalations publication-title: Int. J. Pharm. contributor: fullname: Bolzen – start-page: 388 year: 2015 end-page: 414 ident: bib0150 article-title: Inhalation and nasal drug products: aerosols, sprays, and powders – performance quality tests publication-title: US Pharmacopeial Convention contributor: fullname: USP General Chapter <601> – volume: 51 start-page: 2385 year: 1995 end-page: 2395 ident: bib0020 article-title: Aqueous infrared carboxylate absorbances: aliphatic monocarboxylates publication-title: Spectrochim. Acta. A. Mol. Biomol. Spectrosc. contributor: fullname: McVey – volume: 124 start-page: 360 year: 2003 end-page: 366 ident: bib0110 article-title: Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers publication-title: Chest contributor: fullname: Weers – volume: 96 start-page: 1302 year: 2007 end-page: 1319 ident: bib0045 article-title: Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics publication-title: J. Pharm. Sci. contributor: fullname: Papadopoulos – volume: 26 start-page: 5475 year: 2010 end-page: 5483 ident: bib0005 article-title: Evaluation of the BET method for determining surface areas of MOFs and zeolites that contain ultra-Micropores publication-title: Langmuir contributor: fullname: Snurr – volume: 430 start-page: 26 year: 2012 end-page: 33 ident: bib0080 article-title: Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation publication-title: Int. J. Pharm. contributor: fullname: Price – volume: 343 start-page: 769 year: 1994 ident: bib0120 article-title: Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal publication-title: Lancet contributor: fullname: Jick – volume: 27 start-page: 2131 year: 2010 end-page: 2140 ident: bib0055 article-title: Inhalation performance of physically mixed dry powders evaluated with a simple simulator for human inspiratory flow patterns publication-title: Pharm. Res. contributor: fullname: Okamoto – volume: 362 start-page: 235 year: 2013 end-page: 237 ident: bib0155 article-title: Crystalline coats or hollow crystals as tools for product design in pharmaceutical industry publication-title: J. Cryst. Growth contributor: fullname: Stelzer – volume: 415 start-page: 62 year: 2011 end-page: 72 ident: bib0130 article-title: Effect of crystallisation conditions and feedstock morphology on the aerosolization performance of micronised salbutamol sulphate publication-title: Int. J. Pharm. contributor: fullname: York – volume: 88 start-page: 1547 year: 2008 end-page: 1565 ident: bib0165 article-title: Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn’t the stomach digest itself? publication-title: Physiol. Rev. contributor: fullname: Wallace – volume: 50 start-page: 979 year: 2007 end-page: 983 ident: bib0095 article-title: Diclofenac solubility: independent determination of the intrinsic solubility of three crystal forms publication-title: J. Med. Chem. contributor: fullname: Goodman – volume: 4 start-page: 1047 year: 2010 end-page: 1050 ident: bib0185 article-title: Production of new haemostatic materials by deposition of dispersed proteins onto porous matrices using supercritical carbon dioxide publication-title: Russ. J. Phys. Chem. B contributor: fullname: Khokhlov – volume: 41 start-page: 64 year: 2013 end-page: 74 ident: bib0075 article-title: Effectiveness and safety of topical versus oral nonsteroidal anti-inflammatory drugs: a comprehensive review publication-title: Phys. Sportsmed. contributor: fullname: Sawyer – volume: 50 start-page: 1209 year: 2005 end-page: 1227 ident: bib0140 article-title: Dry powder inhaler formulation publication-title: Respir. Care contributor: fullname: Hickey – volume: 34 start-page: 1422 year: 2005 end-page: 1423 ident: bib0175 article-title: A simple route to form straw-like carbon microbundles publication-title: Chem. Lett. contributor: fullname: Cheng – volume: 6 start-page: 773 year: 2012 end-page: 779 ident: bib0015 article-title: Coverage of prandial insulin requirements by means of an ultra-Rapid-Acting inhaled insulin publication-title: J. Diabetes Sci. Technol. contributor: fullname: Lorber – volume: 41 start-page: 1107 year: 2013 end-page: 1115 ident: bib0170 article-title: Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study publication-title: Eur. Respir. J. contributor: fullname: Hampel – volume: 50 start-page: 1209 year: 2005 ident: 10.1016/j.ijpharm.2016.02.030_bib0140 article-title: Dry powder inhaler formulation publication-title: Respir. Care contributor: fullname: Telko – volume: 415 start-page: 62 year: 2011 ident: 10.1016/j.ijpharm.2016.02.030_bib0130 article-title: Effect of crystallisation conditions and feedstock morphology on the aerosolization performance of micronised salbutamol sulphate publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2011.05.043 contributor: fullname: Shariare – volume: 53 start-page: 794 year: 1997 ident: 10.1016/j.ijpharm.2016.02.030_bib0025 article-title: Two monoclinic forms of diclofenac acid publication-title: Acta Crystallogr. Sect. C doi: 10.1107/S0108270197002126 contributor: fullname: Castellari – volume: 360 start-page: 1 year: 2008 ident: 10.1016/j.ijpharm.2016.02.030_bib0070 article-title: Dry powder inhalers (DPIs)—a review of device reliability and innovation publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2008.04.044 contributor: fullname: Islam – start-page: 523 year: 2015 ident: 10.1016/j.ijpharm.2016.02.030_bib0180 article-title: Effect of capsule fill weight on device resistance in dry powder inhalers contributor: fullname: Yazdi – year: 2012 ident: 10.1016/j.ijpharm.2016.02.030_bib0050 contributor: fullname: Hinds – volume: 124 start-page: 360 year: 2003 ident: 10.1016/j.ijpharm.2016.02.030_bib0110 article-title: Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers publication-title: Chest doi: 10.1378/chest.124.1.360 contributor: fullname: Newhouse – volume: 10 start-page: 365 year: 2010 ident: 10.1016/j.ijpharm.2016.02.030_bib0040 article-title: Formation of tubular crystals of pharmaceutical compounds publication-title: Cryst. Growth Des. doi: 10.1021/cg900969n contributor: fullname: Eddleston – start-page: 1326 year: 2015 ident: 10.1016/j.ijpharm.2016.02.030_bib0145 article-title: Powder flow contributor: fullname: USP General Chapter <1174> – volume: 88 start-page: 1547 year: 2008 ident: 10.1016/j.ijpharm.2016.02.030_bib0165 article-title: Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn’t the stomach digest itself? publication-title: Physiol. Rev. doi: 10.1152/physrev.00004.2008 contributor: fullname: Wallace – ident: 10.1016/j.ijpharm.2016.02.030_bib0115 – start-page: 388 year: 2015 ident: 10.1016/j.ijpharm.2016.02.030_bib0150 article-title: Inhalation and nasal drug products: aerosols, sprays, and powders – performance quality tests contributor: fullname: USP General Chapter <601> – volume: 25 start-page: 999 year: 2008 ident: 10.1016/j.ijpharm.2016.02.030_bib0160 article-title: Pharmaceutical particle engineering via spray drying publication-title: Pharm. Res. doi: 10.1007/s11095-007-9475-1 contributor: fullname: Vehring – start-page: 588 year: 2003 ident: 10.1016/j.ijpharm.2016.02.030_bib0085 article-title: Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications publication-title: Br. J. Clin. Pharmacol. doi: 10.1046/j.1365-2125.2003.01892.x contributor: fullname: Labiris – ident: 10.1016/j.ijpharm.2016.02.030_bib0030 contributor: fullname: Center for Drug Evaluation Research – volume: 430 start-page: 26 year: 2012 ident: 10.1016/j.ijpharm.2016.02.030_bib0080 article-title: Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2012.03.020 contributor: fullname: Kubavat – ident: 10.1016/j.ijpharm.2016.02.030_bib0090 – volume: 33 start-page: 435 year: 1993 ident: 10.1016/j.ijpharm.2016.02.030_bib0105 article-title: Renal toxicity of the nonsteroidal anti-Inflammatory drugs publication-title: Annu. Rev. Pharmacol. Toxicol. doi: 10.1146/annurev.pa.33.040193.002251 contributor: fullname: Murray – ident: 10.1016/j.ijpharm.2016.02.030_bib0035 – volume: 11 start-page: 1642 year: 2010 ident: 10.1016/j.ijpharm.2016.02.030_bib0125 article-title: Micronization of a soft material: air-Jet and micro-Ball milling publication-title: AAPS PharmSciTech doi: 10.1208/s12249-010-9542-5 contributor: fullname: Saleem – volume: 4 start-page: 1047 year: 2010 ident: 10.1016/j.ijpharm.2016.02.030_bib0185 article-title: Production of new haemostatic materials by deposition of dispersed proteins onto porous matrices using supercritical carbon dioxide publication-title: Russ. J. Phys. Chem. B doi: 10.1134/S1990793110070018 contributor: fullname: Zalepugin – volume: 6 start-page: 773 year: 2012 ident: 10.1016/j.ijpharm.2016.02.030_bib0015 article-title: Coverage of prandial insulin requirements by means of an ultra-Rapid-Acting inhaled insulin publication-title: J. Diabetes Sci. Technol. doi: 10.1177/193229681200600406 contributor: fullname: Boss – volume: 88 start-page: 23 year: 2003 ident: 10.1016/j.ijpharm.2016.02.030_bib0060 article-title: A new agglomerated KSR-592 beta-form crystal system for dry powder inhalation formulation to improve inhalation performance in vitro and in vivo publication-title: J. Controlled Release doi: 10.1016/S0168-3659(02)00460-1 contributor: fullname: Ikegami – volume: 41 start-page: 1107 year: 2013 ident: 10.1016/j.ijpharm.2016.02.030_bib0170 article-title: Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study publication-title: Eur. Respir. J. doi: 10.1183/09031936.00071312 contributor: fullname: Wilson – ident: 10.1016/j.ijpharm.2016.02.030_bib0065 – volume: 41 start-page: 64 year: 2013 ident: 10.1016/j.ijpharm.2016.02.030_bib0075 article-title: Effectiveness and safety of topical versus oral nonsteroidal anti-inflammatory drugs: a comprehensive review publication-title: Phys. Sportsmed. doi: 10.3810/psm.2013.05.2016 contributor: fullname: Klinge – volume: 362 start-page: 235 year: 2013 ident: 10.1016/j.ijpharm.2016.02.030_bib0155 article-title: Crystalline coats or hollow crystals as tools for product design in pharmaceutical industry publication-title: J. Cryst. Growth doi: 10.1016/j.jcrysgro.2011.10.060 contributor: fullname: Ulrich – volume: 48 start-page: 107 year: 2011 ident: 10.1016/j.ijpharm.2016.02.030_bib0100 article-title: The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestine publication-title: J. Clin. Biochem. Nutr. doi: 10.3164/jcbn.10-79 contributor: fullname: Matsui – volume: 96 start-page: 1302 year: 2007 ident: 10.1016/j.ijpharm.2016.02.030_bib0045 article-title: Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics publication-title: J. Pharm. Sci. doi: 10.1002/jps.20943 contributor: fullname: Hickey – volume: 27 start-page: 2131 year: 2010 ident: 10.1016/j.ijpharm.2016.02.030_bib0055 article-title: Inhalation performance of physically mixed dry powders evaluated with a simple simulator for human inspiratory flow patterns publication-title: Pharm. Res. doi: 10.1007/s11095-010-0215-6 contributor: fullname: Hira – volume: 343 start-page: 769 year: 1994 ident: 10.1016/j.ijpharm.2016.02.030_bib0120 article-title: Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal publication-title: Lancet doi: 10.1016/S0140-6736(94)91843-0 contributor: fullname: Rodriguez – volume: 270 start-page: 297 year: 2004 ident: 10.1016/j.ijpharm.2016.02.030_bib0135 article-title: Alternative sugars as potential carriers for dry powder inhalations publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2003.10.039 contributor: fullname: Steckel – volume: 34 start-page: 1422 year: 2005 ident: 10.1016/j.ijpharm.2016.02.030_bib0175 article-title: A simple route to form straw-like carbon microbundles publication-title: Chem. Lett. doi: 10.1246/cl.2005.1422 contributor: fullname: Xiao – volume: 51 start-page: 2385 year: 1995 ident: 10.1016/j.ijpharm.2016.02.030_bib0020 article-title: Aqueous infrared carboxylate absorbances: aliphatic monocarboxylates publication-title: Spectrochim. Acta. A. Mol. Biomol. Spectrosc. doi: 10.1016/0584-8539(95)01479-9 contributor: fullname: Cabaniss – volume: 26 start-page: 5475 year: 2010 ident: 10.1016/j.ijpharm.2016.02.030_bib0005 article-title: Evaluation of the BET method for determining surface areas of MOFs and zeolites that contain ultra-Micropores publication-title: Langmuir doi: 10.1021/la100449z contributor: fullname: Bae – volume: 25 start-page: 389 year: 2008 ident: 10.1016/j.ijpharm.2016.02.030_bib0010 article-title: Surface morphology of spray-dried nanoparticle-coated microparticles designed as an oral drug delivery system publication-title: Braz. J. Chem. Eng. doi: 10.1590/S0104-66322008000200016 contributor: fullname: Beck – volume: 50 start-page: 979 year: 2007 ident: 10.1016/j.ijpharm.2016.02.030_bib0095 article-title: Diclofenac solubility: independent determination of the intrinsic solubility of three crystal forms publication-title: J. Med. Chem. doi: 10.1021/jm0612970 contributor: fullname: Llinàs |
SSID | ssj0006213 |
Score | 2.3478744 |
Snippet | [Display omitted]
To crystallize diclofenac (DF) from diclofenac sodium (DFNa), to micronize DF and DFNa, and to evaluate in vitro aerodynamic performance of... To crystallize diclofenac (DF) from diclofenac sodium (DFNa), to micronize DF and DFNa, and to evaluate in vitro aerodynamic performance of the jet-milled... OBJECTIVETo crystallize diclofenac (DF) from diclofenac sodium (DFNa), to micronize DF and DFNa, and to evaluate in vitro aerodynamic performance of the... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 170 |
SubjectTerms | Anti-Inflammatory Agents, Non-Steroidal - chemistry Calorimetry, Differential Scanning Crystallization Diclofenac Diclofenac - chemistry Diclofenac sodium Drug Delivery Systems Dry powder inhaler Dry Powder Inhalers Jet milling Microscopy, Electron, Scanning Next generation impactor Particle Size Powder Diffraction Powders Precipitation Spectroscopy, Fourier Transform Infrared Technology, Pharmaceutical X-Ray Diffraction |
Title | Hollow crystalline straws of diclofenac for high-dose and carrier-free dry powder inhaler formulations |
URI | https://dx.doi.org/10.1016/j.ijpharm.2016.02.030 https://www.ncbi.nlm.nih.gov/pubmed/26911418 https://search.proquest.com/docview/1774533535 |
Volume | 502 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9swFBehvexSum7t0i80GD3ViS1ZtnwspSXbIBTWQm_ixZJYArWDnRJy2d_e9_zRUOgY7GghyUI_6b2fpPfB2LdUOQCRy8ArHQaxoPdd5ekOHrm21t4r2xjITpPJQ_zjUT0O2HXvC0NmlZ3sb2V6I627knE3m-PlfD7-FcomsbxERtF4fJIHO6o_XNOjP1szj0R0KZLxtES1t14848VovlhSgGiy8Eqa0J1kDP2-fvob_2z00O0-2-sIJL9qx_iRDVxxwC7u2gjUm0t-v3Woqi_5Bb_bxqbefGJ-griXa55XG6SFFI_bcbrsWNe89Nxil6V3BeQcuSynUMaBLWvHobA8h4qy2wW-co7basOX5dq6is-L36hkKmrx1OUCqz-zh9ub--tJ0KVaCHJkEKtAyJnMvU4FMoQwty72Hg9nswzCBISVPosgg8x5iBxoDbFXEHqHJ1mrQEcqlYdspygL94XxNMuxmkiFjHWskO8AbnEsgZC8VuNkyEb9BJtlG1HD9KZmC9MhYggREwqDiAyZ7mEwb5aGQan_r6Zfe9gMbht6C4HClc-1iZD2ItNVUg3ZUYvn62hEghogjvTx___4hH2gL3p2iqJTtrOqnt0ZspfV7LxZnuds9-r7z8n0Bes677k |
link.rule.ids | 315,783,787,4509,24128,27936,27937,45597,45691 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PT9swFLYYHLbLBIxt5cfwJMSJ0MSOE-eI0FAYrEKiSNys19jWWmlJlRRV_e95ThwqJKZJuzpxYvmznz_b732PkJNUGABW8MAKGQYxc_e7wrozeOTaUlordOsgO0ryh_jno3jcIJd9LIxzq_S2v7PprbX2JUPfm8P5dDq8D3mbWJ4jo2gjPt-RLWQDGc7OrYvrm3z0YpAT5rMk44bJVVgH8gxn59PZ3GlEOyevpFXvdP7Qby9Rf6Og7VJ0tU0-eg5JL7pm7pANU-6S07tOhHp1RsfrmKrmjJ7Su7U89eoTsTlCXy1pUa-QGTpJbkPdeceyoZWlGj9ZWVNCQZHOUqdmHOiqMRRKTQuoXYK7wNbGUF2v6LxaalPTafkb15na1fjj04E1e-Th6sf4Mg98toWgQBKxCBif8MLKlCFJCAttYmtxfzbJIEyAaW6zCDLIjIXIgJQQWwGhNbiZ1QJkJFL-mWyWVWm-EppmBb7GUsZjGQukPICzHEsgdIGrcTIg530Hq3knqqF6b7OZ8ogoh4gKmUJEBkT2MKhXo0Oh4f9X1e89bApnjrsOgdJUT42KkPki2RVcDMiXDs-X1jAcR1Ecyf3___ExeZ-Pf92q2-vRzQH54J64W6goOiSbi_rJHCGZWUy--cH6DCk78m0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hollow+crystalline+straws+of+diclofenac+for+high-dose+and+carrier-free+dry+powder+inhaler+formulations&rft.jtitle=International+journal+of+pharmaceutics&rft.au=Yazdi%2C+Ashkan+K.&rft.au=Smyth%2C+Hugh+D.C.&rft.date=2016-04-11&rft.issn=0378-5173&rft.volume=502&rft.issue=1-2&rft.spage=170&rft.epage=180&rft_id=info:doi/10.1016%2Fj.ijpharm.2016.02.030&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_ijpharm_2016_02_030 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0378-5173&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0378-5173&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0378-5173&client=summon |